Annual Revenue
$63.53 M
-$32.77 M-34.03%
December 31, 2023
Summary
- As of February 12, 2025, FATE annual revenue is $63.53 million, with the most recent change of -$32.77 million (-34.03%) on December 31, 2023.
- During the last 3 years, FATE annual revenue has risen by +$32.10 million (+102.12%).
- FATE annual revenue is now -34.03% below its all-time high of $96.30 million, reached on December 31, 2022.
Performance
FATE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$3.07 M
-$3.70 M-54.61%
September 30, 2024
Summary
- As of February 12, 2025, FATE quarterly revenue is $3.07 million, with the most recent change of -$3.70 million (-54.61%) on September 30, 2024.
- Over the past year, FATE quarterly revenue has increased by +$1.13 million (+58.13%).
- FATE quarterly revenue is now -94.79% below its all-time high of $58.98 million, reached on March 31, 2023.
Performance
FATE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$13.45 M
+$1.13 M+9.17%
September 30, 2024
Summary
- As of February 12, 2025, FATE TTM revenue is $13.45 million, with the most recent change of +$1.13 million (+9.17%) on September 30, 2024.
- Over the past year, FATE TTM revenue has dropped by -$92.77 million (-87.34%).
- FATE TTM revenue is now -90.18% below its all-time high of $136.87 million, reached on March 31, 2023.
Performance
FATE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
FATE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.0% | +58.1% | -87.3% |
| 3 y3 years | +102.1% | -94.8% | -90.2% |
| 5 y5 years | +1240.4% | +22.2% | +27.3% |
FATE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.0% | +13.8% | -94.8% | +229.5% | -90.2% | +107.6% |
| 5 y | 5-year | -34.0% | +494.9% | -94.8% | +229.5% | -90.2% | +107.6% |
| alltime | all time | -34.0% | +6443.1% | -94.8% | +1370.8% | -90.2% | +3987.2% |
Fate Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.07 M(-54.6%) | $13.45 M(+9.2%) |
| Jun 2024 | - | $6.77 M(+251.8%) | $12.32 M(+90.1%) |
| Mar 2024 | - | $1.93 M(+14.9%) | $6.48 M(-89.8%) |
| Dec 2023 | $63.53 M(-34.0%) | $1.68 M(-13.8%) | $63.53 M(-40.2%) |
| Sep 2023 | - | $1.94 M(+108.4%) | $106.21 M(-10.9%) |
| Jun 2023 | - | $933.00 K(-98.4%) | $119.25 M(-12.9%) |
| Mar 2023 | - | $58.98 M(+33.0%) | $136.87 M(+42.1%) |
| Dec 2022 | $96.30 M(+72.4%) | $44.36 M(+196.1%) | $96.30 M(+39.5%) |
| Sep 2022 | - | $14.98 M(-19.2%) | $69.01 M(+1.1%) |
| Jun 2022 | - | $18.55 M(+0.7%) | $68.26 M(+8.1%) |
| Mar 2022 | - | $18.41 M(+7.9%) | $63.12 M(+13.0%) |
| Dec 2021 | $55.85 M(+77.7%) | $17.07 M(+20.0%) | $55.85 M(+2.1%) |
| Sep 2021 | - | $14.22 M(+6.1%) | $54.67 M(+13.9%) |
| Jun 2021 | - | $13.41 M(+20.4%) | $48.01 M(+19.8%) |
| Mar 2021 | - | $11.14 M(-29.9%) | $40.06 M(+27.4%) |
| Dec 2020 | $31.43 M(+194.3%) | $15.90 M(+110.3%) | $31.43 M(+71.4%) |
| Sep 2020 | - | $7.56 M(+38.3%) | $18.34 M(+38.8%) |
| Jun 2020 | - | $5.46 M(+117.3%) | $13.21 M(+25.1%) |
| Mar 2020 | - | $2.52 M(-10.2%) | $10.56 M(-1.1%) |
| Dec 2019 | $10.68 M | $2.80 M(+15.4%) | $10.68 M(+12.0%) |
| Sep 2019 | - | $2.43 M(-13.8%) | $9.54 M(+17.2%) |
| Jun 2019 | - | $2.82 M(+7.0%) | $8.14 M(+28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $2.63 M(+58.5%) | $6.35 M(+33.9%) |
| Dec 2018 | $4.74 M(+15.4%) | $1.66 M(+61.9%) | $4.74 M(+15.4%) |
| Sep 2018 | - | $1.03 M(-0.1%) | $4.11 M(0.0%) |
| Jun 2018 | - | $1.03 M(+0.1%) | $4.11 M(+0.0%) |
| Mar 2018 | - | $1.03 M(-0.1%) | $4.11 M(-0.0%) |
| Dec 2017 | $4.11 M(-6.7%) | $1.03 M(+0.1%) | $4.11 M(0.0%) |
| Sep 2017 | - | $1.03 M(0.0%) | $4.11 M(0.0%) |
| Jun 2017 | - | $1.03 M(-0.1%) | $4.11 M(-0.0%) |
| Mar 2017 | - | $1.03 M(0.0%) | $4.11 M(-6.7%) |
| Dec 2016 | $4.40 M(+81.1%) | $1.03 M(+0.1%) | $4.40 M(-1.1%) |
| Sep 2016 | - | $1.03 M(-0.1%) | $4.45 M(0.0%) |
| Jun 2016 | - | $1.03 M(-22.3%) | $4.45 M(+18.6%) |
| Mar 2016 | - | $1.32 M(+22.9%) | $3.75 M(+54.4%) |
| Dec 2015 | $2.43 M(+150.4%) | $1.08 M(+4.9%) | $2.43 M(+79.4%) |
| Sep 2015 | - | $1.03 M(+211.9%) | $1.35 M(+311.9%) |
| Jun 2015 | - | $329.00 K(+57.4%) | $329.00 K(-79.6%) |
| Dec 2013 | $971.00 K(-63.6%) | - | - |
| Sep 2013 | - | $209.00 K(-27.9%) | $1.61 M(-16.5%) |
| Jun 2013 | - | $290.00 K(-38.6%) | $1.93 M(+17.7%) |
| Mar 2013 | - | $472.00 K(-26.6%) | $1.64 M(+40.3%) |
| Dec 2012 | $2.67 M(+128.2%) | $643.00 K(+21.8%) | $1.17 M(+121.8%) |
| Sep 2012 | - | $528.00 K | $528.00 K |
| Dec 2011 | $1.17 M | - | - |
FAQ
- What is Fate Therapeutics annual revenue?
- What is the all time high annual revenue for Fate Therapeutics?
- What is Fate Therapeutics annual revenue year-on-year change?
- What is Fate Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Fate Therapeutics?
- What is Fate Therapeutics quarterly revenue year-on-year change?
- What is Fate Therapeutics TTM revenue?
- What is the all time high TTM revenue for Fate Therapeutics?
- What is Fate Therapeutics TTM revenue year-on-year change?
What is Fate Therapeutics annual revenue?
The current annual revenue of FATE is $63.53 M
What is the all time high annual revenue for Fate Therapeutics?
Fate Therapeutics all-time high annual revenue is $96.30 M
What is Fate Therapeutics annual revenue year-on-year change?
Over the past year, FATE annual revenue has changed by -$32.77 M (-34.03%)
What is Fate Therapeutics quarterly revenue?
The current quarterly revenue of FATE is $3.07 M
What is the all time high quarterly revenue for Fate Therapeutics?
Fate Therapeutics all-time high quarterly revenue is $58.98 M
What is Fate Therapeutics quarterly revenue year-on-year change?
Over the past year, FATE quarterly revenue has changed by +$1.13 M (+58.13%)
What is Fate Therapeutics TTM revenue?
The current TTM revenue of FATE is $13.45 M
What is the all time high TTM revenue for Fate Therapeutics?
Fate Therapeutics all-time high TTM revenue is $136.87 M
What is Fate Therapeutics TTM revenue year-on-year change?
Over the past year, FATE TTM revenue has changed by -$92.77 M (-87.34%)